AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions

Cancer, COVID-19 and copycat drugs dominated the agenda at last week's meeting of the European Medicines Agency’s (EMA's) human medicines committee, which has endorsed four new pharmaceuticals and pushed for label extensions on 11 others.